Key result
Comorbid hypertension in pneumonia linked to a ~6% absolute reduction in extended hospital stays.
Why the study?
There is limited evidence regarding the combined effect of pneumonia and hypertension on clinical outcomes, including hospital length of stay.
Does concomitant hypertension reduce the length of hospital stay in patients with pneumonia?
Observational (n=18,141)
Yes
Does concomitant hypertension reduce the length of hospital stay in patients with pneumonia?
Concomitant hypertension in patients hospitalized with pneumonia is paradoxically associated with a shorter length of stay, particularly in elderly patients.
Answers are grounded in this paper and cite their sources.
Concomitant hypertension was associated with shorter pneumonia stays in this cohort; leaves open whether confounding or biology drives the finding, precluding practice change.
Background: Pneumonia is a serious respiratory infection that affects patients across all age groups. While it typically responds to treatment, patients with pre-existing comorbidities are at increased risk of poor outcomes. Hypertension (HTN) is a common condition that may coexist in patients with pneumonia. Although pneumonia and HTN have been studied separately, there is limited evidence regarding their combined effect on clinical outcomes, including hospital length of stay (LOS), treatment duration, and recovery trajectory. Objectives: Identifying factors that influence the length of hospital stay in patients with pneumonia is essential for addressing the burden of hospitalization on both patients and healthcare systems. In this study, we compared the proportion of patients with an extended LOS (≥6 days) between patients with pneumonia with concomitant HTN and those without HTN. Methods: A retrospective review of hospitalization data was conducted for 18,141 patients, who were divided into three groups: patients with both pneumonia and HTN (PXG), patients with pneumonia without HTN (P0G), and patients with HTN without pneumonia (0XG). Results: The analysis revealed a statistically significant reduction in the proportion of patients with an extended LOS in the PXG cohort compared with the P0G cohort. Subgroup analysis indicated that this effect was driven by outcomes in patients aged >65 years (elderly). Conclusions: Our findings suggest that hospitalization for patients with comorbid pneumonia and HTN is associated with a shorter LOS compared with patients with pneumonia without HTN. Unmeasured factors that may influence this association include the use of antihypertensive medications, adherence to lifestyle modifications, and a higher frequency of healthcare encounters.
No takes yet. Share an insight, caveat, or question.
Blau et al. (2026) conducted an observational in Pneumonia and Hypertension (n=18,141). Comorbid hypertension vs. Pneumonia without hypertension was evaluated on Extended length of stay (≥6 days) (6.41% absolute difference, 95% CI 3.72-9.11, p=<0.0001). Comorbid hypertension in patients hospitalized with pneumonia was associated with a 6.41% absolute reduction in extended length of stay (≥6 days) compared to those without hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: